| Name | MCT1-IN-2 |
|---|---|
| Synonyms |
MCT-1-IN-2,MCT1 IN 2,MCT1IN2
2,6-Dihydro-7-[(3-hydroxypropyl)thio]-2-methyl-4-(2-methylpropyl)-6-(1-naphthalenylmethyl)-1H-pyrrolo[3,4-d]pyridazin-1one SR 13800,MCT1 1H-Pyrrolo[3,4-d]pyridazin-1-one, 2,6-dihydro-7-[(3-hydroxypropyl)thio]-2-methyl-4-(2-methylpropyl)-6-(1-naphthalenylmethyl) MCT1 Inhibitor, SR13800 |
| Description | MCT1-IN-2 is a potent monocarboxylate transporter 1 (MCT1) inhibitor. MCT1-IN-2 has anti-cancer activity[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | MCT1-IN-2 (compound 3) has a pKi of 9.48 for Jurkat T-cells and inhibits human peripheral blood mononuclear cells (PBMC) proliferation (pIC50=8.61)[1]. MCT1-IN-2 (compound 1) has an EC50 of 5.5 nM (MTT assay) and an IC50 of 105 nM (lactate transport inhibition assay) in human Raji lymphoma cell proliferation[2]. |
| References |
| Molecular Formula | C25H29N3O2S |
|---|---|
| Molecular Weight | 435.58 |